GADA 2018 GADA vs David Ashurava

In October 2018 the Georgian Anti-Doping Agency (GADA) has reported an anti-doping rule violation against the cyclist David Ashurava after his sample tested positive for the prohibited substances Meldonium, Metandienone, Stanozolol.

After notification a provisional suspension was ordered and the Athlete was heard for the Anti-Doping Disciplinary Panel of the Georgian Anti-Doping Agency and Eastern Europe Anti-Doping Organization.

The Athlete denied the intentional use of the substances and believed that the supplement he had purchased on the internet was the source of the prohibited substances.

The Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that the committed an anti-doping rule violation. Further the Panel considers that the Athlete failed to provide evidence that the alleged supplement was the source of the positive test.

Therefore the Panel decides on 22 April 2019 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 18 October 2018.

Original document

Parameters

Legal Source
National Decisions
Date
22 April 2019
Arbitrator
Chelidze, Sergo
Lobjhanidze, Givi
Meladze, Valeri
Pkhaladze, Zaur
Country
Georgia
Language
English
Georgian
ADRV
Adverse Analytical Finding / presence
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Georgian Anti-Doping Agency (GADA)
Laboratories
Seibersdorf, Austria: Seibersdorf Labor GmbH Doping Control Laboratory
Doping classes
S1. Anabolic Agents
S4. Hormone And Metabolic Modulators
Substances
Meldonium
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Stanozolol
Document type
Pdf file
Date generated
26 April 2022
Date of last modification
4 May 2022
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin